Rosen Discusses FDA Issues and Policies

02 August 2019 Law360 News

Partner David Rosen, who chairs the firm’s FDA regulatory practice, was quoted in a Law360 article, “FDA Focus: What Foley & Lardner’s Practice Chair is Watching,” about litigation and regulation he’s watching, the skills he looks for when hiring an FDA lawyer and the one FDA policy he’d change if he had a magic wand.

Rosen said the firm does a lot of work with compliance and enforcement, especially with data integrity issues. He also said he’s always been a “stickler” about making sure products meet appropriate standards of identity, strength, quality and purity at the time of use.

Related Services

Insights

Top Five New Telehealth Policies in Medicare 2021 in Physician Fee Schedule
02 December 2020
Health Care Law Today
IMMEX Highlights – Sub-maquila Operations
02 December 2020
Dashboard Insights
Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
European Data Protection Board Issues Recommendations for Exports of Personal Data From the European Economic Area
01 December 2020
Privacy, Cybersecurity & Technology Law Perspectives
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar